UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000056712
Receipt number R000064827
Scientific Title Exploring the effects of orbital diseases on intraorbital tissues
Date of disclosure of the study information 2025/04/01
Last modified on 2025/01/14 17:08:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exploring the effects of orbital diseases on intraorbital tissues

Acronym

Exploring the effects of orbital diseases on intraorbital tissues

Scientific Title

Exploring the effects of orbital diseases on intraorbital tissues

Scientific Title:Acronym

Exploring the effects of orbital diseases on intraorbital tissues

Region

Japan


Condition

Condition

orbital disease

Classification by specialty

Ophthalmology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

We will clarify the pathology of orbital diseases on the orbital tissue from the perspective of histology and biochemistry. We will also clarify the relationship between the severity of orbital diseases and these factors.

Basic objectives2

Others

Basic objectives -Others

Concentration of fibrosis markers

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Concentration of inflammatory cytokines in orbital tissue

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

10 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

All patients undergoing orbital surgery

Key exclusion criteria

Patients who have not reached the appropriate age

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Hideyuki
Middle name
Last name Shimizu

Organization

Nagoya University

Division name

Department of Ophthalmology

Zip code

466-8550

Address

65 Tsurumai, Showa-ku, Nagoya

TEL

052-744-2277

Email

h.shimizu@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name Hideyuki
Middle name
Last name Shimizu

Organization

Nagoya University

Division name

Department of Ophthalmology

Zip code

466-8550

Address

65 Tsurumai, Showa-ku, Nagoya

TEL

052-744-2277

Homepage URL


Email

h.shimizu@med.nagoya-u.ac.jp


Sponsor or person

Institute

Department of Ophthalmology, Nagoya University

Institute

Department

Personal name



Funding Source

Organization

Department of Ophthalmology, Nagoya University

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagoya University

Address

65 Tsurumai, Showa-ku, Nagoya

Tel

052-744-2277

Email

h.shimizu@med.nagoya-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 01 Month 01 Day

Date of IRB


Anticipated trial start date

2025 Year 04 Month 01 Day

Last follow-up date

2029 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Nothing


Management information

Registered date

2025 Year 01 Month 14 Day

Last modified on

2025 Year 01 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064827